Literature Review: The Role of Medium Chain-Triglyceride (MCT) in Improving Lipid Profiles in Dyslipidemia

Background: Dyslipidemia is a lipid metabolism disorder that causes changes in plasma lipoprotein function and/or levels of Triglycerides (TG), total cholesterol (TC), Low-Density Lipoprotein (LDL), and High-Density (HDL). Administration Medium Chain Triglyceride (MCT) non-pharmacological therapy effectively improves profiles reduces the risk dyslipidemia. Objectives: This study aimed to conduct literature regarding role MCTs improving dyslipidemic conditions. Discussion: MCT has profile. One food source contains MCT, which blood cholesterol, TG, LDL levels, Virgin Coconut Oil (VCO). About 60% MCFA VCO consists 52% lauric acid 12% myristic acid, can benefit metabolism. In addition, foods containing have lowering reducing TG levels. Not only do they play but also increase HDL concentrations. Conclusions: conditions, namely by increasing